Abstract
INTRODUCTION
Inflammation is of importance in cancer development, and many tumours develop due to prolonged or chronic inflammation throughout their progression [1] . Carcinogenesis in colorectal cancer (CRC) is a multistep process maintained by accumulation of genetic and epigenetic aberrations in several pathways [2, 3] . Also, local immunoregulation mediated by inflammatory cells, such as white blood cells, of the tumour microenvironment are involved in the release of inflammatory factors that are able to activate local immune networks to pro mote both the development and growth of malignant CRC cells by increasing their proliferation, survival and angiogenesis [1, 4] . Inflammatory factors such as cytokines together with angiogenic factors are able to trigger the development of invasive abilities as they increase the migration and motility of tumour cells, resulting in the occurrence of metastasis [1] . Cytokines, which include chemokines and interleukins, are a broad and loose category of small proteins produced by white blood cells, stromal cells and cancer cells [1, 5] . They are able to regulate the intensity and duration of the immune response by either stimulating or inhibiting the activation, proliferation and/or differentiation of various cells and are also able to regulate the secretion of antibodies and other cytokines [5] . By targeting selected cytokine networks or pathways one may be able to restrain CRC tumorigenesis or even improve the response rate in CRC tumours to chemotherapies, and there are several clinical trials that have focused on evaluating the blockage of different cytokines [68] . Increased levels of inflammatory factors have been associated with increased mortality in CRC patients, also in stage Ⅰ which has a good oncological prognosis, but also in asymptomatic assumed healthy individuals [912] . The aim of this paper was to study the association of plasma levels of cytokines, chemokines and interleukins in CRC patients at the time of surgery with survival. The hypothesis is that strong inflammation at the time of surgery is associated with worse prognosis.
MATERIALS AND METHODS

Study population
This study involved analysis of plasma samples from 174 CRC patients from southeastern Sweden who had undergone surgical resections for primary colorectal adenocarcinoma between 20062013 at the Department of Surgery, County Hospital Ryhov, Region of Jönköping County, Jönköping, Sweden. The clinicopathological characteristics of the patients were obtained from surgical and pathological records. Followup was performed by consulting the medical records from all hospital departments and the primary care up to January 31, 2016. The date of an eventual cancer recurrence and the date and cause of death as related to CRCspecific mortality or not were deter mined from a review of the patient's files. The study was approved by the Regional Ethical Review Board in Linköping, Linköping, Sweden, and written informed consent was obtained from each patient.
Plasma samples
Venous blood samples were collected at the time of surgery and centrifuged to separate plasma and blood cells. Plasma was stored at 80 ℃ until analysis. Plasma samples were available from 174 patients (69 females and 105 men), and their median age was 70 years (range 2990). The patients' tumours were localized in the colon (n = 105) or rectum (n = 69) and were classified as stage Ⅰ (n = 24), stage Ⅱ (n = 54), stage Ⅲ (n = 67) and stage Ⅳ (n = 29). 
Human cytokine assay
RESULTS
Clinical baseline characteristics
The clinical baseline characteristics of the total study population are presented in 
Associations between TNM stage and levels of inflammatory factors
Each of the inflammatory factors were tested for any eventual association with TNM stage by the Jonkheere Terpstra test.Only CCL20, CCL27, IL8 and MIF were associated with TNM stage (Table 2) .
Total mortality in relation to high tertile levels of inflammatory factors
In a univariate Cox regression analysis, the highest tertile levels of 14 factors, CCL1, CCL3, CCL15, CCL20, CX3CL1, CXCL1, CXCL10, CXCL13, IFNγ, IL1β, IL2, IL4, IL8/CXCL8 and IL10, were significantly associated with total mortality (Table 3) . CX3CL1 had the highest hazard ratio (HR) of 3.3 with a 95%CI of 1.86.1, p < 0.001, for the highest tertile. Nine of the factors in the univariate analysis, CCL1, CCL15, CCL20, CX3CL1, CXCL13, IFNγ, IL2, IL4 and IL10, remained significant after adjustment of clinical covariates with p < 0.20, such as TNM stage, radical surgery, preoperative and adjuvant treatment and age. Figure  1 shows an example of a KaplanMeier analysis of plasma levels of IFNγ and an increased risk of total mortality. The KaplanMeier curves illustrate mortality as a function of followup time in relation to tertile levels.
CRC-specific mortality in relation to high levels of inflammatory factors
When investigating the CRC specific mortality among the inflammatory factors, the univariate Cox regression analysis revealed that the highest tertile levels of 8 factors, CCL1, CCL3, CCL15, CCL20, CX3CL1, CXCL16, IL4 and IL8/CXCL8, were significantly associated with CRC specific mortality (Table 4) . CCL20 showed the highest HR of 4, CI of 1.610.1, p < 0.01. After adjustment for clinical covariates with p < 0.20, only 4 factors remained significant, CCL1, CCL20, CX3CL1 and IL4. In addition, TNFα and CCL24 became significant after this adjustment. KaplanMeier analysis of CRC specific mortality and tertile levels of CCL1 is shown in Figure 2 . In summary, higher tertile levels of the inflammatory factors CCL1, CCL20, CX3CL1 and IL4 were all associated with increased risk of both total and CRC a commercial multiplex kit, which allow simultaneous quantification of several factors of interest, to determine whether the plasma levels of these factors were associated with CRC prognosis.
We found that high tertile levels of CCL1, CCL20, CX3CL1 and IL4 were associated with increased CRC specific mortality in a multivariate Cox regression analysis. We also found an increased total mortality in association of high tertile levels of CCL1, CCL15, CCL20, CX3CL1, CXCL13, IFNγ, IL2, IL4 and IL10.
Several studies have focused on higher or lower levels of some of the inflammatory factors included in our study such as CCL15, CCL20, CX3CL1, CXCL13, CXCL16, IL4, IL8/CXCL8, IL10 and TNFα by either comparing expression levels in tissue, in serum or specific mortality after Cox regression analysis when adjusted for clinical covariates. Higher tertile levels of TNFα and CCL24 were exclusively associated with CRCspecific mortality. For most of the inflammatory factors the association between higher tertile levels and an increased mortality in general appeared two years after surgery. Twenty three inflammatory factors did not have any association with CRCspecific or total mortality when studying the followup time in relation to the tertile levels of these factors (Table 5) .
DISCUSSION
In this study, we screened plasma samples from 174 CRC patients for 40 different inflammatory factors using in plasma from CRC patients and controls or among patients only [1322] . Also, expression levels of some of these factors have been studied in relation to survival [1315, 17, 18, 2022] . More recent studies have found an association of increased levels of inflammatory markers and increased mortality in CRC patients, but also in CRC patients stage Ⅰ and in asymptomatic healthy individuals [912] . Our findings of a worse prognosis in association with increased level of inflammation may therefore be a more general phenomenon and not directly related to the cancer disease. As mentioned, the local immunoregulation mediated by inflammatory cells, such as white blood cells, of the tumour microenvironment are important for the release of inflammatory factors such as cytokines, which are able to activate local immune networks to promote both the development and growth of malignant CRC cells [1, 4] . White blood cells play an important part in immunoregulation but play dual roles. They are supposed to defeat the cancer development by producing cytokines and activating inflammatory signalling pathways enabling necrosis or apoptosis of cancer cells. But the cancer itself may also induce an immunomodulation of the white blood cells, making them unable to produce cytokines and other inflammatory factors. In this way, the cancer cells avoid inflammatory recognition and are then able to continue their development [1, 4] . The CX3CL1 chemokine is expressed by epithelial cells in both CRC and normal colorectal mucosa. Higher levels of this chemokine have been associated with better prognosis and higher survival rate in CRC patients, depending on antitumour immunity through a higher number of attracted lymphocytes [16] . This is contradictory to our findings in the univariate analysis, which show an association between higher tertile levels of CX3CL1 and a > 3.5fold increased risk for CRC specific mortality among our CRC patients.
The CCL15 chemokine has a strong chemotactic activity for myeloid cells such as dendritic cells, monocytes, neutrophils and some Tlymphocytes [23] . In a study by Inamoto et al [13] a trend between higher levels of CCL15 and poor survival among CRC patients was observed. In this study we confirm that a higher inflammatory tertile level of CCL15 is related to CRC specific mortality when we do not include age as a covariate in the statistical analysis. Expression of the CCL20 chemokine has been demonstrated in dendritic cells, macrophages, eosino philic granulocytes and in B and Tcell lymphocytes, as reviewed by Schutyser et al [24] . In CRC, higher serum levels of CCL20 may serve as a potential biomarker for prognosis. It may also be useful for identification of patients with increased risk of disease recurrence in stage Ⅱ CRC [14] . In the present investigation, higher tertile levels of CCL20 in plasma is associated with a 4fold increased risk for CRCspecific mortality in the univariate analysis, which could be explained by a relation to TNM stage.
IL4 is produced by basophils, activated Tlymphocytes and mast cells and seems to be upregulated in CRC [25, 26] . It has been suggested that IL4 might be involved in the process of supporting the tumourinitiating cells, enabling them to escape immune surveillance and in turn promote CRC progression [19] . Our data show that the highest tertile level of IL4 is associated with an increased risk of CRC specific mortality as a result of ongoing CRC progression over time.
The CCL1 chemokine is secreted from fibroblasts [27] and Th2 cells [28] . CCL1 has been implicated in other types of cancer but little is known about its effects on CRC [27] . The Th2cells express the CCR8 receptor [29, 30] , which is activated by CCL1 [31] , and it mediates Th2 cell recruitment to sites of inflammation [32, 33] . In cancer, the CCL1CCR8 autocrine loop has been shown to have a protective function by enabling lymphoma and T cell leukaemia cells to avoid apoptosis in vitro [34, 35] and to play a role in T cell transformation [36] . In this study, higher tertile levels of this chemokine were associated with a 2.8 fold increased risk for CRCspecific mortality and one might speculate that the CCL1CCR8 autocrine loop may help CRC cells to progress their development and spread. Due to our results CCL1 might be a new important factor to consider in further studies regarding its implications on CRC.
There are several limitations identified in our study that need to be taken into consideration. First, a control group was not included in the present work since our focus was on survival among CRC patients, making us unable to study differences and/or associations in levels of the inflammatory factors among patients and healthy individuals. However, there are already several studies that have investigated differences in levels of cytokines among both patients and healthy control subjects [37, 38] . Second, our cohort was relatively small influencing the statistical evaluation and especially associations with stage, which was weak due to low power. This also makes it difficult to stratify the patients into respect to more variables such as type of surgery, with inflammatory complicated CRC such as peritumorous abscess, perforation or peritonitis, or inflammatory bowel disease. Third, it is also important to realize that the level of inflammatory factors in the circulation might reflect the release of factors during cancer carcinogenesis, due to other underlying diseases or by systemic inflammation in general. In this study we did not have the possibility to investigate this.
Future aspects should focus on studying these inflammatory factors in a larger CRC patient cohort to see if they might have the potential as biomarkers that can be measured through a rapid, simple, non invasive and less costly plasma analysis enabling the identification of CRC patients with worse prognosis. Functional studies are needed to elucidate weather these are causative factors for tumour progression or a biomarker for CRC prognosis or a marker for a general fragility. CCL2  CCL27  CCL7  CXCL2  CCL8  CXCL5  CCL11  CXCL6  CCL13  CXCL9  CCL17  CXCL11  CCL19  CXCL12  CCL21 GM-CSF CCL22 IL-6 CCL23 IL-16 CCL25 MIF CCL26
In summary, high tertile levels of a range of chemo kines, cytokines and interleukins are associated with a worse prognosis in patients operated for CRC, both as expressed as cancer specific mortality (CCL1, CCL20, CCL24, CX3CL1, IL4 and TNFα) and total mortality (CCL1, CCL15, CCL20, CX3CL1, CXCL13, IFNγ, IL2, IL4 and IL10). This suggests that the observed association of a worse prognosis in CRC patients with an increased level of inflammation may not only be associated to the cancer disease but expression of a fragile host.
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